Is Innospec, Inc. overvalued or undervalued?

As of 24 October 2025, the valuation grade for Innospec, Inc. has moved from attractive to fair. The company appears to be fairly valued based on its current metrics. Key ratios include a P/E ratio of 14, an EV to EBITDA of 10.31, and a PEG ratio of 0.82, which suggest that the stock is reasonably priced compared to its earnings growth potential.
In comparison to peers, Eastman Chemical Co. has a higher P/E of 15.68, while Element Solutions, Inc. shows a significantly higher EV to EBITDA at 14.82, indicating that Innospec may be more attractively priced relative to these competitors. Over the past year, Innospec has underperformed the S&P 500, with a return of -30.17% compared to the index's 16.90%, reinforcing the notion that the stock may be facing challenges despite its fair valuation.